otiti
media
om
amongst
common
childhood
diseas
associ
multipl
microbi
pathogen
within
middl
ear
global
tempor
monitor
predomin
bacteri
pathogen
import
inform
new
treatment
strategi
vaccin
develop
monitor
impact
vaccin
implement
improv
progress
toward
global
om
prevent
systemat
review
publish
report
microbiolog
acut
otiti
media
aom
otiti
media
effus
ome
januari
august
perform
use
pubm
databas
review
confirm
streptococcu
pneumonia
haemophilu
influenza
remain
predomin
bacteri
pathogen
pneumonia
predomin
bacterium
major
report
aom
patient
contrast
h
influenza
predomin
bacterium
patient
experienc
chronic
ome
recurr
aom
aom
treatment
failur
result
consist
even
improv
detect
sensit
use
polymeras
chain
reaction
pcr
rather
bacteri
cultur
conduct
averag
pcr
analys
increas
frequenc
detect
pneumonia
h
influenza
fold
compar
cultur
whilst
moraxella
catarrhali
time
frequent
identifi
pcr
molecular
method
also
improv
monitor
region
chang
serotyp
identif
frequenc
pneumonia
h
influenza
time
vaccin
implement
introduct
pneumococc
conjug
vaccin
otiti
media
may
simpli
defin
inflamm
middl
ear
common
reason
child
age
visit
gener
practition
prescrib
antibiot
socioeconom
develop
countri
om
rang
clinic
present
includ
aom
characteris
rapid
onset
local
system
symptom
includ
otalgia
fever
vomit
accumul
fluid
middl
ear
caviti
ome
child
experi
mef
accumul
without
system
symptom
present
may
occur
recurr
chronic
global
million
case
aom
diagnos
year
affect
children
five
year
age
recurr
aom
raom
occur
patient
diagnos
aom
episod
within
six
month
episod
month
commonli
observ
children
year
age
ome
typic
resolv
spontan
within
month
howev
children
experi
persist
chronic
fluid
middl
ear
month
chronic
ome
come
may
requir
surgic
intervent
aid
resolut
irrespect
clinic
present
om
multifactori
diseas
mani
associ
risk
factor
includ
environment
immunolog
defici
gender
age
microbi
exposur
despit
complex
bacteri
viral
pathogen
individu
togeth
strongli
associ
om
develop
exampl
children
diagnos
aom
bacteri
viral
pathogen
detect
use
cultur
pcr
three
bacteria
frequent
identifi
associ
om
pneumonia
h
influenza
catarrhali
whilst
virus
commonli
associ
om
respiratori
syncyti
viru
adenoviru
rhinoviru
coronaviru
monitor
identif
frequenc
detect
common
otopathogen
om
central
evalu
effect
treatment
impact
vaccin
program
exampl
pneumococc
carriag
reduc
associ
introduct
heptaval
pneumococc
conjug
vaccin
us
also
increas
prevent
earli
aom
infect
implement
nation
immunis
program
nip
also
result
shift
nonvaccin
pneumococc
serotyp
isol
invas
pneumococc
diseas
om
importantli
implement
result
nontyp
nonencapsul
h
influenza
nthi
detect
frequenc
surpass
pneumonia
detect
aom
patient
within
number
countri
includ
us
spain
franc
emerg
nonvaccin
serotyp
potenti
role
pathogen
om
area
ongo
research
interest
systemat
review
examin
frequenc
detect
bacteria
within
mef
children
experienc
om
global
ongo
surveil
bacteria
predomin
om
patient
improv
detect
method
pcr
monitor
impact
immunis
continu
inform
treatment
decis
ultim
vaccin
develop
aim
prevent
om
develop
young
children
design
construct
systemat
review
inform
complianc
prisma
see
prisma
checklist
publish
literatur
includ
confer
abstract
search
via
pubm
databas
origin
articl
english
abstract
retriev
review
public
date
restrict
januari
st
august
th
five
differ
search
strategi
use
detail
follow
term
use
five
literatur
search
search
region
otiti
media
asia
aetiolog
otopathogen
pathogen
microbiolog
bacteriolog
bacteria
otiti
media
bangladesh
brunei
cambodia
china
india
indonesia
iran
israel
japan
korea
lao
lebanon
malaysia
pakistan
philippin
saudi
arabia
singapor
taiwan
thailand
turkey
vietnam
fig
search
region
otiti
media
america
aetiolog
otopathogen
pathogen
microbiolog
bacteriolog
bacteria
otiti
media
argentina
brazil
chile
colombia
costa
rica
cuba
dominica
republ
ecuador
hondura
mexico
panama
paraguay
uruguay
venezuela
canada
us
fig
search
region
otiti
media
africa
aetiolog
otopathogen
pathogen
microbiolog
bacteriolog
bacteria
otiti
media
algeria
cameroon
cote
dlvoir
egypt
mozambiqu
namibia
nigeria
south
africa
zambia
zimbabw
fig
search
region
otiti
media
europ
aetiolog
otopathogen
pathogen
microbiolog
bacteriolog
bacteria
articl
english
assess
relev
review
abstract
avail
prior
full
review
articl
predetermin
inclus
select
criteria
use
human
studi
ii
age
rang
one
year
major
report
studi
popul
year
old
iii
otopathogen
bacteria
identifi
mef
sampl
children
experienc
rang
present
om
includ
aomraomaomtf
ome
come
chronic
suppur
om
csom
iv
mef
sampl
collect
clinic
perfor
tympan
membran
myringotomi
tympanocentesi
rather
spontan
perfor
articl
meet
keyword
criteria
identifi
primari
databas
search
screen
independ
relev
two
author
ccn
hmm
read
articl
titl
abstract
standardis
manner
abstract
articl
review
compar
inclus
criteria
key
data
evalu
report
detail
studi
popul
age
type
om
sampl
size
sampl
collect
method
microbiolog
method
year
studi
record
includ
studi
furthermor
detail
sampl
collect
method
clinic
criteria
diagnosi
type
om
inconclus
full
paper
retriev
review
determin
inclus
discuss
review
resolv
disagr
regard
inclus
addit
inform
sought
author
includ
review
via
email
request
seek
addit
unpublish
inform
regard
vaccin
statu
andor
serotyp
data
avail
studi
popul
clarifi
inform
sampl
method
use
publish
studi
bibliographi
includ
studi
manual
search
addit
relev
refer
data
illustr
frequenc
detect
predomin
bacteria
report
collat
record
antibiot
sensit
bacteria
vaccin
statu
particip
record
avail
data
tabl
within
narr
report
compil
primari
result
includ
report
metaanalysi
perform
due
variat
design
includ
studi
studi
popul
characterist
within
publish
report
studi
includ
studi
previous
publish
peer
review
journal
varieti
individu
studi
design
prevent
use
valid
instrument
assess
qualiti
includ
studi
assess
risk
bia
individu
studi
perform
studi
level
use
inclus
criteria
exampl
clinic
criteria
describ
vari
present
om
may
vari
thirti
year
publish
literatur
review
review
author
ensur
publish
studi
clearli
differenti
acut
aom
presenc
otalgia
inflam
andor
bulg
tympan
membran
remain
consist
characterist
within
current
definit
vaccin
statu
studi
popul
unknown
comparison
studi
date
versu
implement
nip
use
inform
potenti
vaccin
statu
studi
sampl
mef
clinic
perfor
tympan
membran
includ
report
criterion
like
gener
select
bia
basi
mef
collect
perform
primarili
research
purpos
rather
clinic
treatment
reason
like
outcom
would
result
skew
represent
includ
sever
case
undergo
surgic
treatment
addit
rel
pauciti
report
world
region
report
america
n
europ
n
asia
n
africa
n
oceania
n
fig
within
america
european
asian
region
report
analys
describ
differ
countri
within
region
contrast
within
african
oceania
region
report
restrict
two
countri
south
africa
egypt
australia
new
zealand
respect
clinic
variant
om
present
includ
review
aom
n
studi
omecom
n
raomaomtf
n
raomom
n
within
includ
studi
n
percentag
greater
due
studi
one
type
om
investig
studi
includ
review
report
microbiolog
find
mef
collect
via
clinic
perfor
tympan
membran
microbiolog
aom
raomaomtf
come
bacteri
isol
overview
systemat
review
includ
report
bacteri
isol
use
cultur
techniqu
mef
sampl
patient
experienc
aom
n
mean
percentag
sampl
posit
bacteria
rang
raomaomtf
n
mean
percentag
sampl
posit
bacteria
rang
ome
come
n
mean
percentag
sampl
posit
bacteria
rang
across
world
eight
studi
report
bacteri
identif
one
clinic
present
om
bacteri
isol
identif
perform
use
pcr
bacteri
cultur
report
report
aom
patient
rather
raom
ome
come
patient
wide
varieti
bacteria
isol
review
studi
patient
aom
raomaomtf
omecom
shown
tabl
respect
frequenc
detect
pneumonia
h
influenza
catarrhali
report
identifi
three
predomin
bacteri
pathogen
bacteria
isol
mef
includ
streptococcu
pyogen
group
streptococcu
staphylococcu
aureu
pseudomona
aeruginosa
staphylococcu
epidermidi
chlamydia
trachomati
alloiococcu
otitidi
klebsiella
pneumonia
escherichia
coli
varieti
microbiota
isol
identifi
report
clearli
vari
experiment
design
aim
methodolog
studi
thu
preclud
direct
comparison
frequenc
individu
pathogen
detect
thu
review
focuss
rel
frequenc
predomin
bacteri
pathogen
previou
report
differ
clinic
present
collat
examin
region
identif
three
predomin
bacteria
within
mef
children
experienc
aom
raomaomtf
omecom
present
tabl
respect
tabl
summaris
publish
report
bacteria
isol
identifi
mef
use
bacteri
cultur
tabl
aom
bacterium
frequent
identifi
mef
children
diagnos
aom
previou
report
across
world
pneumonia
close
follow
h
influenza
see
tabl
averag
pneumonia
detect
significantli
higher
h
influenza
previou
studi
pool
p
anova
without
replic
report
includ
sampl
collect
region
mef
aom
patient
averag
frequenc
pneumonia
higher
nthi
detect
region
although
signific
differ
averag
detect
frequenc
bacteria
us
nthi
versu
pneumonia
contrast
nthi
predomin
bacteria
compar
averag
frequenc
bacteri
detect
region
report
raomaomtf
south
america
europ
oceania
two
studi
conduct
costa
rica
show
pneumonia
predomin
raom
within
world
region
trend
toward
frequent
detect
pneumonia
averag
frequenc
pneumonia
higher
nthi
detect
region
inde
multipl
report
avail
countri
within
region
report
number
countri
includ
finland
colombia
usa
japan
show
chang
predomin
bacteria
identifi
multipl
studi
usa
provid
evid
tempor
trend
detect
frequenc
chang
pneumonia
studi
recruit
tabl
omecom
tabl
examin
raomaomtf
report
n
n
respect
demonstr
predomin
bacteria
overal
tabl
although
averag
bacteri
detect
frequenc
h
influenza
demonstr
rang
comparison
rang
pneumonia
catarrhali
detect
low
detect
report
averag
detect
frequenc
bacteri
cultur
rang
signific
region
tempor
trend
observ
due
pauciti
studi
challeng
aris
recruit
overlap
clinic
present
raomaomtf
within
differ
studi
design
omecom
overal
mef
sampl
patient
diagnos
omecom
less
like
cultur
posit
predomin
bacteria
comparison
mef
sampl
patient
diagnos
aom
evidenc
averag
frequenc
detect
h
influenza
pneumonia
omecom
patient
approxim
half
report
aom
patient
vs
vs
bacteria
respect
global
h
influenza
predomin
bacteria
identifi
within
mef
patient
experienc
omecom
p
anova
without
replic
averag
detect
frequenc
rang
compar
pneumonia
detect
rang
region
h
influenza
identifi
frequent
patient
omecom
south
north
america
europ
asia
africa
oceania
howev
asian
european
region
four
nine
two
nine
studi
report
pneumonia
predomin
respect
within
review
bacteri
pathogen
associ
om
mef
examin
region
evid
develop
antibiot
resist
record
resist
report
includ
summari
region
provid
overal
gener
pauciti
report
h
influenza
strain
antibiot
sensit
report
mef
om
patient
gener
avail
report
highlight
high
proport
nthi
isol
compar
h
influenza
strain
identifi
aom
patient
across
almost
world
region
america
europ
asia
oceania
evid
avail
africa
proport
h
influenza
isol
aom
patient
posit
rang
less
region
report
mexico
consist
pattern
recognis
region
multipl
report
avail
h
influenza
isol
come
patient
gener
report
proport
posit
strain
major
report
across
world
identifi
high
proport
catarrhali
strain
posit
south
america
aomassoci
h
influenza
strain
isol
within
south
america
predominantli
nthi
rang
h
influenza
type
b
c
f
identifi
aom
patient
chile
venezuela
less
aomassoci
h
influenza
strain
posit
contrast
recent
studi
mexico
report
aomassoci
h
influenza
strain
posit
whilst
report
demonstr
aomassoci
catarrhali
strain
posit
north
america
aomrel
h
influenza
strain
report
nontyp
strain
posit
furthermor
catarrhali
strain
isol
aom
patient
posit
recent
two
studi
report
h
influenza
bacteria
detect
often
mef
children
aom
sinc
introduct
pneumococc
vaccin
nip
europ
recent
studi
germani
report
aomrel
h
influenza
strain
nontyp
h
influenza
type
b
f
also
identifi
low
frequenc
franc
aomassoci
h
influenza
strain
isol
posit
aomrel
catarrhali
strain
posit
posit
strain
h
influenza
report
strain
isol
omecom
patient
england
spain
respect
asia
h
influenza
strain
associ
aom
region
nontyp
h
influenza
type
b
identifi
low
frequenc
strain
isol
turkey
posit
furthermor
h
influenza
isol
children
come
lebanon
ampicillinresist
strain
howev
strain
type
africa
report
h
influenza
type
aom
patient
african
region
howev
singl
report
egypt
confirm
comeassoci
h
influenza
catarrhali
strain
isol
posit
respect
oceania
oceania
h
influenza
isol
raom
patient
australia
nontyp
strain
strain
posit
similarli
new
zealand
omrel
h
influenza
strain
nontyp
singl
report
comeassoci
h
influenza
strain
new
zealand
report
type
b
type
b
recommend
high
risk
group
mexico
subsequ
introduc
mexico
nip
furthermor
introduct
nip
high
risk
group
within
individu
countri
region
may
also
impact
aetiolog
om
within
region
demonstr
impact
immunis
aetiolog
om
sinc
introduct
includ
reduct
serotyp
detect
om
replac
serotyp
aom
nonvaccin
serotyp
particularli
serotyp
chang
domin
otopathogen
h
influenza
pneumonia
south
america
introduc
partial
costa
rica
venezuela
mexico
vaccin
implement
nip
costa
rica
mexico
overal
rate
pneumococc
om
reduc
south
american
region
introduct
ratio
pneumonia
h
influenza
isol
patient
om
exampl
costa
rica
frequenc
pneumonia
isol
patient
om
decreas
similarli
mexico
proport
pneumonia
isol
patient
om
drop
persist
serotyp
demonstr
earli
follow
studi
costa
rica
mexico
within
year
introduct
serotyp
identifi
pneumococc
isol
patient
om
respect
countri
emerg
nonvaccin
serotyp
observ
countri
serotyp
account
identifi
pneumococc
isol
costa
rica
serotyp
identifi
serotyp
om
patient
mexico
pcv
introduct
longer
term
year
introduct
venezuela
predomin
pneumococc
serotyp
isol
children
om
serotyp
identifi
serotyp
follow
serotyp
overal
emerg
serotyp
concurr
overal
reduct
frequenc
pneumococc
isol
children
om
north
america
first
introduc
unit
state
prevent
invas
pneumococc
diseas
children
age
month
receiv
least
dose
introduct
predomin
pathogen
identifi
om
us
chang
pneumonia
h
influenza
prior
introduct
pneumonia
common
bacteria
isol
patient
aom
year
follow
pcv
implement
h
influenza
emerg
common
isol
patient
om
chang
pneumonia
serotyp
caus
aom
observ
introduct
unit
state
pcv
introduct
vaccin
serotyp
account
pneumococc
strain
isol
middl
ear
sampl
children
aom
one
two
year
postvaccin
introduct
serotyp
account
omassoci
pneumococc
strain
isol
middl
ear
sampl
six
eight
year
later
observedreport
amongst
pneumococc
strain
isol
mef
sampl
children
om
serotyp
predomin
serotyp
account
omrel
pneumonia
strain
isol
mef
sampl
serotyp
pneumonia
identifi
lower
frequenc
mef
sampl
om
children
recent
year
although
pneumococc
serotyp
frequenc
pneumonia
h
influenza
isol
equival
europ
survey
countri
report
countri
recommend
univers
immun
children
remain
countri
use
vaccin
group
high
risk
infect
use
vaccin
univers
impact
vaccin
om
aetiolog
pneumococc
serotyp
identifi
om
patient
observ
countri
vaccin
introduc
follow
introduct
domin
otopathogen
chang
pneumonia
h
influenza
franc
greec
franc
prior
introduct
pneumonia
otopathogen
commonli
identifi
account
isol
follow
h
influenza
howev
year
follow
introduct
h
influenza
becam
domin
bacteria
identifi
within
approxim
isol
follow
pneumonia
chang
pattern
evid
year
post
implement
pneumonia
commonli
isol
speci
mostli
serotyp
similarli
greec
pneumonia
isol
middl
ear
sampl
children
aom
decreas
post
pcv
introduct
h
influenza
increas
slightli
introduct
vaccin
result
chang
pneumococc
serotyp
isol
patient
om
franc
vaccin
introduct
period
prior
identifi
criterion
rate
complet
vaccin
infant
year
age
serotyp
account
pneumonia
associ
om
year
introduct
decreas
less
similarli
spain
percentag
serotyp
drop
pneumococc
strain
isol
patient
om
follow
introduct
frequenc
serotyp
increas
patient
om
franc
spain
asia
singapor
israel
introduc
nip
studi
israel
report
serotyp
account
approxim
pneumonia
strain
associ
om
prior
vaccin
introduct
studi
identifi
review
report
rate
follow
introduct
microbi
aetiolog
om
countri
region
africa
introduc
nip
south
africa
gambia
rwanda
singl
studi
south
africa
examin
pneumonia
serotyp
show
serotyp
account
omassoci
pneumonia
nigeria
shift
predomin
bacteria
amongst
three
main
otopathogen
detect
mef
sampl
patient
aom
observ
although
inform
introduct
report
earli
pneumonia
report
predomin
otopathogen
follow
h
influenza
catarrhali
howev
recent
h
influenza
report
predomin
otopathogen
follow
catarrhali
pneumonia
oceania
licenc
recommend
australian
aborigin
children
year
age
children
high
risk
pneumococc
infect
recommend
extend
children
australia
pneumococc
serotyp
recov
middl
ear
sampl
show
progress
chang
immunis
introduct
vaccin
serotyp
account
approxim
pneumococci
isol
ear
discharg
ear
swab
australian
children
year
age
year
inclus
nip
serotyp
replac
vaccin
serotyp
isol
middl
ear
sampl
nonaborigin
children
om
account
identifi
serotyp
serotyp
made
contrast
region
h
influenza
alway
report
common
otopathogen
isol
aborigin
nonaborigin
children
om
australia
thu
shift
h
influenza
pneumonia
predomin
otopathogen
observ
preand
introduct
countri
similar
observ
report
new
zealand
h
influenza
identifi
common
bacteria
isol
children
om
raom
omecom
pneumococc
vaccin
introduct
frequenc
bacteri
detect
within
mef
sampl
children
om
compar
use
cultur
pcr
across
world
studi
report
bacteri
identif
major
n
examin
mef
patient
come
raom
report
aom
patient
overal
pcr
detect
method
improv
detect
frequenc
bacteria
although
magnitud
improv
vari
individu
report
rang
differ
increas
bacteri
detect
averag
improv
frequenc
detect
bacteria
identifi
within
mef
children
om
time
higher
use
pcr
compar
bacteri
cultur
pneumonia
h
influenza
sensit
pcr
techniqu
also
improv
catarrhali
detect
averag
across
studi
tabl
enhanc
sensit
detect
observ
use
pcr
result
detect
catarrhali
pneumonia
cultur
neg
sampl
pcr
confirm
predomin
bacterium
identifi
within
sampl
observ
report
howev
report
show
differ
predomin
bacteria
chang
catarrhali
chang
h
influenza
predomin
bacterium
identifi
one
studi
pcr
identifi
differ
predomin
bacterium
recognis
pattern
compar
cultur
result
chang
h
influenza
pneumonia
predomin
bacterium
cultur
global
consist
result
bacteri
cultur
pcr
result
confirm
overal
h
influenza
frequent
detect
bacterium
mef
children
experienc
comeraom
studi
catarrhali
predomin
studi
three
bacteria
equal
frequent
one
studi
iran
two
studi
examin
aom
patient
mef
identifi
catarrhali
frequent
although
alloiococcu
otitidi
otitidi
equal
frequent
identifi
report
region
pcr
result
h
influenza
detect
frequent
america
asia
oceania
europ
h
influenza
catarrhali
equal
frequent
studi
pcr
detect
otitidi
mef
om
patient
report
rang
countri
includ
turkey
japan
iran
finland
sweden
unit
kingdom
unit
state
collect
otitidi
detect
mef
sampl
om
patient
pcr
larg
undetect
use
cultur
tabl
furthermor
otitidi
frequent
identifi
patient
ome
compar
patient
aom
commonli
detect
bacteria
middl
ear
patient
omecom
detect
use
pcr
use
pcr
methodolog
improv
detect
rate
organ
difficult
cultur
exampl
detect
otitidi
within
mef
sampl
patient
om
requir
day
cultur
thu
pcr
analysi
mef
sampl
improv
detect
organ
result
consider
otitidi
role
om
pathogenesi
frequenc
bacteri
pathogen
om
identifi
within
middl
ear
fluid
use
primarili
microbi
cultur
also
pcr
review
rang
clinic
present
use
report
publish
sinc
review
focuss
pathogen
actual
identifi
within
mef
rather
extrapol
upper
respiratori
tract
pathogen
coincid
nasopharynx
improv
understand
polymicrobi
natur
om
vari
clinic
present
inform
identif
specif
bacteria
virus
within
middl
ear
overal
frequenc
bacteri
isol
mef
sampl
patient
aom
gener
higher
present
includ
raomaomtf
ome
come
find
consist
recognit
aom
acut
frequent
bacteri
caus
infect
whilst
ome
come
consid
consequ
previou
aom
episod
inflamm
result
presenc
bacteri
biofilm
intracellular
infect
within
middl
ear
epitheli
cell
come
ome
may
also
result
inflammatori
allerg
condit
rhinosinus
review
confirm
om
polymicrobi
diseas
predomin
microb
identifi
mef
sampl
patient
aom
raom
aomtf
ome
come
global
consist
previou
report
three
bacteria
frequent
identifi
mef
cultur
consid
causal
om
pneumonia
h
influenza
catarrhali
latin
american
countri
streptococcu
pyogen
pyogen
also
frequent
identifi
predomin
bacterium
pathogen
om
increasingli
otitidi
identifi
within
mef
use
pcr
techniqu
although
bacterium
role
om
pathogenesi
still
investig
cultur
base
detect
otitidi
within
mef
sampl
patient
om
requir
day
cultur
thu
organ
may
success
identifi
report
previou
studi
pneumonia
remain
frequent
detect
bacteria
patient
aom
asia
africa
america
europ
signific
differ
clinic
manifest
aom
result
differ
pneumococc
serotyp
identifi
gener
serotyp
report
caus
otalgia
ear
ach
addit
children
aom
caus
pneumonia
report
experi
higher
fever
red
tympan
membran
aom
caus
h
influenza
catarrhali
thu
increas
likelihood
present
medic
treatment
aom
associ
pneumonia
less
like
resolv
without
treatment
compar
caus
catarrhali
overal
use
initi
reduc
incid
aom
caus
pneumonia
alter
serotyp
causal
aom
replac
serotyp
nonvaccin
serotyp
observ
mef
sampl
children
om
countri
vaccin
use
serotyp
predomin
serotyp
recov
vaccin
children
om
new
genotyp
serotyp
isol
children
aom
resist
usa
food
drug
administr
approv
antimicrobi
drug
aom
treatment
children
therefor
pneumococc
conjug
vaccin
includ
serotyp
may
help
reduc
incid
om
sinc
licens
recommend
children
number
develop
countri
unit
state
unit
kingdom
singapor
australia
contrast
aom
h
influenza
frequent
detect
bacteria
mef
patient
raom
omecom
global
except
australia
second
common
pathogen
patient
aom
across
world
australia
h
influenza
predomin
bacterium
aom
ome
indigen
nonindigen
children
bilater
aom
eye
symptom
previou
treatment
antibiot
protract
recurr
diseas
like
aom
caus
h
influenza
compar
caus
pathogen
studi
includ
review
less
h
influenza
strain
recov
patient
om
produc
respons
bacteri
resist
antibiot
commonli
use
first
line
treatment
om
aminopenicillin
cephalosporin
cephamycin
carbapenem
widespread
use
antibiot
treatment
om
contribut
develop
antimicrobi
resist
ampicillinresist
blnar
h
influenza
strain
isol
mef
patient
om
mexico
lebanon
japan
blnar
strain
identifi
mef
latter
two
report
isol
elsewher
upper
respiratori
tract
reflect
frequent
detect
mechan
ampicillin
resist
h
influenza
across
world
although
base
mef
sampl
recent
report
describ
chang
frequenc
identif
blnar
h
influenza
isol
global
region
confirm
reduct
detect
europ
africa
whilst
proport
detect
rose
region
includ
latin
america
middl
east
review
nthi
strain
frequent
report
strain
unaffect
h
influenza
b
conjug
vaccin
alon
hib
increasingli
inclus
h
influenza
antigen
improv
opportun
vaccin
develop
develop
introduct
associ
increas
identif
h
influenza
patient
om
compar
pneumonia
h
influenza
gradual
replac
pneumonia
predomin
otopathogen
children
aom
year
follow
introduct
absenc
approv
vaccin
nthi
prevent
shift
could
creat
anoth
challeng
treatment
prevent
om
recent
nthi
vaccin
research
interest
focuss
pneumococc
nthi
protein
conjug
vaccin
contain
pneumococc
serotyp
protein
h
influenza
vaccin
immunogen
protein
well
toler
studi
conduct
america
europ
asia
africa
australia
origin
consid
potenti
candid
replac
recent
studi
australia
demonstr
nthi
strain
isol
nasal
caviti
nasopharynx
bronchoalveolar
lavag
fluid
asymptomat
carriag
children
bronchiectasi
miss
hpd
gene
encod
protein
nthi
research
need
trial
number
alreadi
identifi
nthi
vaccin
candid
respect
safeti
immunogen
efficaci
om
catarrhali
recognis
otopathogen
sinc
signific
increas
detect
occur
sinc
clinic
catarrhali
alon
appear
least
virul
pathogen
often
associ
first
episod
diseas
younger
age
onset
lower
rate
spontan
tympan
membran
perfor
increas
likelihood
spontan
resolut
catarrhali
howev
frequent
occur
polymicrobi
infect
review
cultur
find
predomin
bacteria
identifi
differ
identifi
pcr
method
catarrhali
new
predomin
bacteriummost
studi
report
catarrhali
strain
isol
patient
om
produc
although
lower
rate
report
turkey
nigeria
whilst
sever
vaccin
candid
identifi
catarrhali
develop
vaccin
strategi
catarrhali
earli
stage
otiti
media
associ
bacteria
includ
pyogen
group
streptococcu
fourth
rank
otopathogen
identifi
review
bacterium
otopathogen
often
identifi
older
children
experi
low
rate
fever
respiratori
symptom
increas
rate
spontan
perfor
mastoid
compar
aom
due
otopathogen
specul
role
pyogen
om
aetiolog
mayb
underrecognis
region
increasingli
new
organ
otitidi
turicella
otitidi
pseudomona
otitidi
corynebacterium
mucifacien
detect
patient
om
signific
om
pathogenesi
remain
unclear
organ
otitidi
commonli
identifi
mef
patient
omecom
otitidi
may
associ
protract
clinic
cours
develop
mucoid
mef
characterist
ome
recent
report
induc
inflamm
within
middl
ear
caviti
thu
potenti
contribut
secondari
pathogen
aom
perfor
review
report
global
detect
bacteri
otopathogen
mef
children
experienc
om
although
three
bacteria
pneumonia
h
influenza
catarrhali
domin
geograph
differ
emerg
differ
relat
pcv
use
antimicrobi
treatment
potenti
local
region
factor
highlight
need
ongo
surveil
report
microbiolog
om
global
order
better
understand
pathogenesi
diseas
guid
develop
appropri
intervent
strategi
despit
pauciti
comprehens
prospect
studi
examin
microbi
aetiolog
aomraom
omecom
local
within
middl
ear
children
throughout
world
conclud
pneumonia
h
influenza
catarrhali
remain
remark
consist
past
year
predomin
bacteria
causal
om
depend
region
detect
method
pneumonia
h
influenza
vie
predomin
bacteria
frequent
isol
middl
ear
fluid
children
om
signific
environment
chang
introduct
ongo
monitor
serotyp
replac
throughout
mani
region
world
continu
provid
evid
predomin
two
bacteria
children
om
importantli
identifi
address
evolv
develop
bacteri
resist
product
potenti
pathogen
preval
microb
pyogen
otitidi
ongo
monitor
essenti
futur
research
essenti
whether
develop
vaccin
includ
multipl
otopathogen
bacteri
viral
triall
use
probiot
supplement
upper
respiratori
tract
children
high
risk
om
investig
continu
aim
minimis
incid
inde
prevent
om
pathogenesi
long
term
sequela
vulner
children
across
world
